home / stock / bicx / bicx quote
Last: | $1.47 |
---|---|
Change Percent: | -0.68% |
Open: | $1.48 |
Close: | $1.47 |
High: | $1.48 |
Low: | $1.05 |
Volume: | 2,656 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.47 | $1.48 | $1.47 | $1.48 | $1.05 | 2,656 | 04-19-2024 |
$1.47 | $0 | $1.47 | $0 | $0 | 4 | 04-18-2024 |
$1.47 | $1.47 | $1.47 | $1.47 | $1.47 | 200 | 04-16-2024 |
$1.5 | $0 | $1.5 | $0 | $0 | 2 | 04-15-2024 |
$1.5 | $1.15 | $1.5 | $1.5 | $1.15 | 790 | 04-12-2024 |
$1.13 | $1.25 | $1.13 | $1.35 | $1.13 | 2,095 | 04-11-2024 |
$1.5 | $0 | $1.5 | $0 | $0 | 5 | 04-10-2024 |
$1.5 | $1.25 | $1.5 | $1.5 | $1.25 | 814 | 04-09-2024 |
$1.2 | $1.145 | $1.2 | $1.2 | $1.145 | 5,605 | 04-08-2024 |
$1.13 | $0 | $1.13 | $0 | $0 | 50 | 04-05-2024 |
$1.13 | $1.13 | $1.13 | $1.13 | $1.13 | 100 | 04-04-2024 |
$1.15 | $1 | $1.15 | $1.16 | $1 | 2,803 | 04-03-2024 |
$0.93 | $0.91 | $0.93 | $0.93 | $0.91 | 1,641 | 04-02-2024 |
$0.895 | $0.8977 | $0.895 | $0.8977 | $0.895 | 1,700 | 04-01-2024 |
$0.895 | $0.874 | $0.895 | $0.895 | $0.874 | 3,400 | 03-29-2024 |
$0.895 | $0.874 | $0.895 | $0.895 | $0.874 | 3,400 | 03-28-2024 |
$0.9 | $0 | $0.9 | $0 | $0 | 10 | 03-27-2024 |
$0.9 | $0.825 | $0.9 | $0.9 | $0.825 | 1,300 | 03-26-2024 |
$0.89 | $0.9 | $0.89 | $0.9 | $0.89 | 1,960 | 03-25-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 725 | 03-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB:BICX) (the "Company"), a developer of innovative trea...
ANAHEIM, CA - ( NewMediaWire ) - April 03, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmace...
ANAHEIM, CA - ( NewMediaWire ) - April 02, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on...